JP2007500013A - 生物学的バーコード - Google Patents
生物学的バーコード Download PDFInfo
- Publication number
- JP2007500013A JP2007500013A JP2006532530A JP2006532530A JP2007500013A JP 2007500013 A JP2007500013 A JP 2007500013A JP 2006532530 A JP2006532530 A JP 2006532530A JP 2006532530 A JP2006532530 A JP 2006532530A JP 2007500013 A JP2007500013 A JP 2007500013A
- Authority
- JP
- Japan
- Prior art keywords
- oligonucleotides
- oligonucleotide
- composition
- sample
- unique
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108091034117 Oligonucleotide Proteins 0.000 claims abstract description 1519
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims abstract description 716
- 239000000523 sample Substances 0.000 claims abstract description 562
- 239000000203 mixture Substances 0.000 claims abstract description 247
- 238000000034 method Methods 0.000 claims abstract description 142
- 239000012472 biological sample Substances 0.000 claims abstract description 21
- 239000002773 nucleotide Substances 0.000 claims description 233
- 125000003729 nucleotide group Chemical group 0.000 claims description 233
- 239000000758 substrate Substances 0.000 claims description 127
- 150000007523 nucleic acids Chemical class 0.000 claims description 113
- 238000009396 hybridization Methods 0.000 claims description 111
- 102000039446 nucleic acids Human genes 0.000 claims description 105
- 108020004707 nucleic acids Proteins 0.000 claims description 105
- 239000000126 substance Substances 0.000 claims description 68
- 230000003321 amplification Effects 0.000 claims description 59
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 59
- 238000003860 storage Methods 0.000 claims description 31
- 108020004414 DNA Proteins 0.000 claims description 28
- 102000053602 DNA Human genes 0.000 claims description 28
- 238000003752 polymerase chain reaction Methods 0.000 claims description 27
- 230000000295 complement effect Effects 0.000 claims description 22
- 102000040430 polynucleotide Human genes 0.000 claims description 19
- 108091033319 polynucleotide Proteins 0.000 claims description 19
- 239000002157 polynucleotide Substances 0.000 claims description 19
- 230000027455 binding Effects 0.000 claims description 16
- 238000001514 detection method Methods 0.000 claims description 14
- -1 polyethylene Polymers 0.000 claims description 13
- 239000012620 biological material Substances 0.000 claims description 12
- 230000001580 bacterial effect Effects 0.000 claims description 11
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 11
- 229920002477 rna polymer Polymers 0.000 claims description 11
- 230000003612 virological effect Effects 0.000 claims description 10
- 229920001184 polypeptide Polymers 0.000 claims description 9
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 9
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 108090000790 Enzymes Proteins 0.000 claims description 7
- 102000004190 Enzymes Human genes 0.000 claims description 7
- 210000004369 blood Anatomy 0.000 claims description 7
- 239000008280 blood Substances 0.000 claims description 7
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 claims description 6
- 210000004027 cell Anatomy 0.000 claims description 6
- 239000002360 explosive Substances 0.000 claims description 6
- 239000011521 glass Substances 0.000 claims description 6
- 235000013372 meat Nutrition 0.000 claims description 6
- 210000001519 tissue Anatomy 0.000 claims description 6
- 101710163270 Nuclease Proteins 0.000 claims description 5
- 241000700605 Viruses Species 0.000 claims description 5
- 229920002678 cellulose Polymers 0.000 claims description 5
- 239000001913 cellulose Substances 0.000 claims description 5
- 239000003814 drug Substances 0.000 claims description 5
- 229940079593 drug Drugs 0.000 claims description 5
- 235000013305 food Nutrition 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- 239000003755 preservative agent Substances 0.000 claims description 5
- 241000894006 Bacteria Species 0.000 claims description 4
- 235000013361 beverage Nutrition 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 241000251468 Actinopterygii Species 0.000 claims description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 3
- 235000019687 Lamb Nutrition 0.000 claims description 3
- 102000004856 Lectins Human genes 0.000 claims description 3
- 108090001090 Lectins Proteins 0.000 claims description 3
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 claims description 3
- 239000004743 Polypropylene Substances 0.000 claims description 3
- 239000004793 Polystyrene Substances 0.000 claims description 3
- 206010036790 Productive cough Diseases 0.000 claims description 3
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 claims description 3
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 claims description 3
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 claims description 3
- 235000013334 alcoholic beverage Nutrition 0.000 claims description 3
- 235000015278 beef Nutrition 0.000 claims description 3
- 239000013060 biological fluid Substances 0.000 claims description 3
- 210000001175 cerebrospinal fluid Anatomy 0.000 claims description 3
- 239000002299 complementary DNA Substances 0.000 claims description 3
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 claims description 3
- 235000013601 eggs Nutrition 0.000 claims description 3
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 claims description 3
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 claims description 3
- 239000002523 lectin Substances 0.000 claims description 3
- 239000003446 ligand Substances 0.000 claims description 3
- 235000019520 non-alcoholic beverage Nutrition 0.000 claims description 3
- 244000052769 pathogen Species 0.000 claims description 3
- 210000002381 plasma Anatomy 0.000 claims description 3
- 229920001155 polypropylene Polymers 0.000 claims description 3
- 229920002223 polystyrene Polymers 0.000 claims description 3
- 235000015277 pork Nutrition 0.000 claims description 3
- 230000002335 preservative effect Effects 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 230000004044 response Effects 0.000 claims description 3
- 210000000582 semen Anatomy 0.000 claims description 3
- 210000002966 serum Anatomy 0.000 claims description 3
- 241000894007 species Species 0.000 claims description 3
- 210000003802 sputum Anatomy 0.000 claims description 3
- 208000024794 sputum Diseases 0.000 claims description 3
- 229940116269 uric acid Drugs 0.000 claims description 3
- 210000002700 urine Anatomy 0.000 claims description 3
- 235000013311 vegetables Nutrition 0.000 claims description 3
- 239000004698 Polyethylene Substances 0.000 claims description 2
- 239000010947 jewellery metal Substances 0.000 claims description 2
- 229910052751 metal Inorganic materials 0.000 claims description 2
- 239000002184 metal Substances 0.000 claims description 2
- 210000003097 mucus Anatomy 0.000 claims description 2
- 229920000573 polyethylene Polymers 0.000 claims description 2
- 239000010970 precious metal Substances 0.000 claims description 2
- 238000001179 sorption measurement Methods 0.000 claims description 2
- 229940122426 Nuclease inhibitor Drugs 0.000 claims 2
- 108091060211 Expressed sequence tag Proteins 0.000 claims 1
- 239000013056 hazardous product Substances 0.000 claims 1
- 230000001717 pathogenic effect Effects 0.000 claims 1
- 238000012545 processing Methods 0.000 description 49
- 239000000047 product Substances 0.000 description 38
- 238000006243 chemical reaction Methods 0.000 description 28
- 238000003491 array Methods 0.000 description 20
- 238000002156 mixing Methods 0.000 description 15
- 108090000623 proteins and genes Proteins 0.000 description 15
- 238000010586 diagram Methods 0.000 description 14
- 239000007788 liquid Substances 0.000 description 14
- 239000000463 material Substances 0.000 description 14
- 102000004169 proteins and genes Human genes 0.000 description 14
- 238000004458 analytical method Methods 0.000 description 13
- 239000000243 solution Substances 0.000 description 13
- 108091093037 Peptide nucleic acid Proteins 0.000 description 12
- 230000000670 limiting effect Effects 0.000 description 12
- 238000005194 fractionation Methods 0.000 description 11
- 239000007787 solid Substances 0.000 description 10
- 230000006870 function Effects 0.000 description 9
- 238000001502 gel electrophoresis Methods 0.000 description 9
- 239000000123 paper Substances 0.000 description 8
- 238000012790 confirmation Methods 0.000 description 7
- 238000000926 separation method Methods 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 6
- 239000007850 fluorescent dye Substances 0.000 description 6
- 238000012986 modification Methods 0.000 description 6
- 230000004048 modification Effects 0.000 description 6
- 230000003287 optical effect Effects 0.000 description 6
- 229920000642 polymer Polymers 0.000 description 6
- 238000012163 sequencing technique Methods 0.000 description 6
- 108091028043 Nucleic acid sequence Proteins 0.000 description 5
- 108091005461 Nucleic proteins Chemical group 0.000 description 5
- 230000009102 absorption Effects 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 5
- 239000006260 foam Substances 0.000 description 5
- 239000011159 matrix material Substances 0.000 description 5
- 229920000728 polyester Polymers 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 238000009792 diffusion process Methods 0.000 description 4
- 238000001962 electrophoresis Methods 0.000 description 4
- 239000005022 packaging material Substances 0.000 description 4
- 239000004033 plastic Substances 0.000 description 4
- 229920003023 plastic Polymers 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 239000011324 bead Substances 0.000 description 3
- 229960002685 biotin Drugs 0.000 description 3
- 235000020958 biotin Nutrition 0.000 description 3
- 239000011616 biotin Substances 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 125000000524 functional group Chemical group 0.000 description 3
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 3
- 230000002452 interceptive effect Effects 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 230000036961 partial effect Effects 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 239000013077 target material Substances 0.000 description 3
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 2
- 229930024421 Adenine Natural products 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 238000000018 DNA microarray Methods 0.000 description 2
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
- 230000002745 absorbent Effects 0.000 description 2
- 239000002250 absorbent Substances 0.000 description 2
- 229960000643 adenine Drugs 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000004422 calculation algorithm Methods 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000011111 cardboard Substances 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000007385 chemical modification Methods 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000000295 emission spectrum Methods 0.000 description 2
- 230000007717 exclusion Effects 0.000 description 2
- 238000003205 genotyping method Methods 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 238000004255 ion exchange chromatography Methods 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 239000002751 oligonucleotide probe Substances 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 238000004816 paper chromatography Methods 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 238000013515 script Methods 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 238000001542 size-exclusion chromatography Methods 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- ACOJCCLIDPZYJC-UHFFFAOYSA-M thiazole orange Chemical compound CC1=CC=C(S([O-])(=O)=O)C=C1.C1=CC=C2C(C=C3N(C4=CC=CC=C4S3)C)=CC=[N+](C)C2=C1 ACOJCCLIDPZYJC-UHFFFAOYSA-M 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- QGKMIGUHVLGJBR-UHFFFAOYSA-M (4z)-1-(3-methylbutyl)-4-[[1-(3-methylbutyl)quinolin-1-ium-4-yl]methylidene]quinoline;iodide Chemical compound [I-].C12=CC=CC=C2N(CCC(C)C)C=CC1=CC1=CC=[N+](CCC(C)C)C2=CC=CC=C12 QGKMIGUHVLGJBR-UHFFFAOYSA-M 0.000 description 1
- WYDKPTZGVLTYPG-UHFFFAOYSA-N 2,8-diamino-3,7-dihydropurin-6-one Chemical compound N1C(N)=NC(=O)C2=C1N=C(N)N2 WYDKPTZGVLTYPG-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- LMNPKIOZMGYQIU-UHFFFAOYSA-N 5-(trifluoromethyl)-1h-pyrimidine-2,4-dione Chemical compound FC(F)(F)C1=CNC(=O)NC1=O LMNPKIOZMGYQIU-UHFFFAOYSA-N 0.000 description 1
- SVXNJCYYMRMXNM-UHFFFAOYSA-N 5-amino-2h-1,2,4-triazin-3-one Chemical compound NC=1C=NNC(=O)N=1 SVXNJCYYMRMXNM-UHFFFAOYSA-N 0.000 description 1
- NJYVEMPWNAYQQN-UHFFFAOYSA-N 5-carboxyfluorescein Chemical compound C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C21OC(=O)C1=CC(C(=O)O)=CC=C21 NJYVEMPWNAYQQN-UHFFFAOYSA-N 0.000 description 1
- BZTDTCNHAFUJOG-UHFFFAOYSA-N 6-carboxyfluorescein Chemical compound C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C11OC(=O)C2=CC=C(C(=O)O)C=C21 BZTDTCNHAFUJOG-UHFFFAOYSA-N 0.000 description 1
- CLGFIVUFZRGQRP-UHFFFAOYSA-N 7,8-dihydro-8-oxoguanine Chemical compound O=C1NC(N)=NC2=C1NC(=O)N2 CLGFIVUFZRGQRP-UHFFFAOYSA-N 0.000 description 1
- PFUVOLUPRFCPMN-UHFFFAOYSA-N 7h-purine-6,8-diamine Chemical compound C1=NC(N)=C2NC(N)=NC2=N1 PFUVOLUPRFCPMN-UHFFFAOYSA-N 0.000 description 1
- RGKBRPAAQSHTED-UHFFFAOYSA-N 8-oxoadenine Chemical compound NC1=NC=NC2=C1NC(=O)N2 RGKBRPAAQSHTED-UHFFFAOYSA-N 0.000 description 1
- MSSXOMSJDRHRMC-UHFFFAOYSA-N 9H-purine-2,6-diamine Chemical compound NC1=NC(N)=C2NC=NC2=N1 MSSXOMSJDRHRMC-UHFFFAOYSA-N 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 241000219195 Arabidopsis thaliana Species 0.000 description 1
- 108090001008 Avidin Proteins 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 229920003043 Cellulose fiber Polymers 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 108020004394 Complementary RNA Proteins 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
- 229930010555 Inosine Natural products 0.000 description 1
- 241001430197 Mollicutes Species 0.000 description 1
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical group C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 1
- 206010028140 Mucous stools Diseases 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 108010004729 Phycoerythrin Proteins 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 102100026827 Protein associated with UVRAG as autophagy enhancer Human genes 0.000 description 1
- 101710102978 Protein associated with UVRAG as autophagy enhancer Proteins 0.000 description 1
- 108020004518 RNA Probes Proteins 0.000 description 1
- 239000003391 RNA probe Substances 0.000 description 1
- 108091028664 Ribonucleotide Proteins 0.000 description 1
- 241000239226 Scorpiones Species 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- 241000700647 Variola virus Species 0.000 description 1
- FRYDSOYOHWGSMD-UHFFFAOYSA-N [C].O Chemical class [C].O FRYDSOYOHWGSMD-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000002306 biochemical method Methods 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 125000003636 chemical group Chemical group 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 239000003184 complementary RNA Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 239000005547 deoxyribonucleotide Substances 0.000 description 1
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000010291 electrical method Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 238000011223 gene expression profiling Methods 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000000984 immunochemical effect Effects 0.000 description 1
- 229960003786 inosine Drugs 0.000 description 1
- 238000001155 isoelectric focusing Methods 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000009940 knitting Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 108060004506 lycopene beta-cyclase Proteins 0.000 description 1
- 239000006249 magnetic particle Substances 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- YACKEPLHDIMKIO-UHFFFAOYSA-N methylphosphonic acid Chemical compound CP(O)(O)=O YACKEPLHDIMKIO-UHFFFAOYSA-N 0.000 description 1
- 238000002493 microarray Methods 0.000 description 1
- 238000012775 microarray technology Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 239000003068 molecular probe Substances 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 229910000510 noble metal Inorganic materials 0.000 description 1
- 239000000820 nonprescription drug Substances 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 238000003499 nucleic acid array Methods 0.000 description 1
- 238000007899 nucleic acid hybridization Methods 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 229920000620 organic polymer Polymers 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 125000004043 oxo group Chemical group O=* 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 239000011087 paperboard Substances 0.000 description 1
- 238000010647 peptide synthesis reaction Methods 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 150000004713 phosphodiesters Chemical class 0.000 description 1
- 238000000206 photolithography Methods 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920001748 polybutylene Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000006916 protein interaction Effects 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 150000003212 purines Chemical class 0.000 description 1
- 150000003230 pyrimidines Chemical class 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 239000002336 ribonucleotide Substances 0.000 description 1
- 125000002652 ribonucleotide group Chemical group 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 description 1
- MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 238000000539 two dimensional gel electrophoresis Methods 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
- 229940075420 xanthine Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/426,940 US20040219533A1 (en) | 2003-04-29 | 2003-04-29 | Biological bar code |
| PCT/US2004/013545 WO2005012574A2 (en) | 2003-04-29 | 2004-04-29 | Biological bar-code |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007500013A true JP2007500013A (ja) | 2007-01-11 |
| JP2007500013A5 JP2007500013A5 (enExample) | 2007-06-21 |
Family
ID=33309996
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006532530A Pending JP2007500013A (ja) | 2003-04-29 | 2004-04-29 | 生物学的バーコード |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US20040219533A1 (enExample) |
| EP (1) | EP1623045A2 (enExample) |
| JP (1) | JP2007500013A (enExample) |
| WO (1) | WO2005012574A2 (enExample) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006169336A (ja) * | 2004-12-15 | 2006-06-29 | Nissan Motor Co Ltd | 情報化核酸含有透明樹脂組成物 |
| JP2006169337A (ja) * | 2004-12-15 | 2006-06-29 | Nissan Motor Co Ltd | 不透明樹脂組成物 |
| JP2017112841A (ja) * | 2015-12-21 | 2017-06-29 | 株式会社テクノサイエンス | 検体管理方法 |
| JPWO2020129462A1 (ja) * | 2018-12-21 | 2021-11-11 | ソニーグループ株式会社 | 粒子確認方法、粒子捕捉用チップ、及び粒子分析システム |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10122836A1 (de) * | 2001-05-11 | 2002-11-28 | November Ag Molekulare Medizin | Faser, Faden und Verfahren zur Markierung und Identifizierung |
| US20050026181A1 (en) * | 2003-04-29 | 2005-02-03 | Genvault Corporation | Bio bar-code |
| US20100075858A1 (en) * | 2003-04-29 | 2010-03-25 | Genvault Corporation | Biological bar code |
| US20050048506A1 (en) * | 2003-09-03 | 2005-03-03 | Fredrick Joseph P. | Methods for encoding non-biological information on microarrays |
| US20080274454A1 (en) * | 2004-04-07 | 2008-11-06 | Mirkin Chad A | Reversible and Chemically Programmable Micelle Assembly With Dna Block-Copolymer Amphiphiles |
| EP2168975A3 (en) | 2004-05-24 | 2012-01-11 | Genvault Corporation | Method of stably storing biomolecules in recoverable form |
| US20060073506A1 (en) * | 2004-09-17 | 2006-04-06 | Affymetrix, Inc. | Methods for identifying biological samples |
| GB0421529D0 (en) | 2004-09-28 | 2004-10-27 | Landegren Gene Technology Ab | Microfluidic structure |
| CA2641271A1 (en) | 2006-02-03 | 2008-03-13 | Microchip Biotechnologies, Inc. | Microfluidic devices |
| WO2008033042A2 (en) * | 2006-09-12 | 2008-03-20 | Agresearch Limited | Method for identifying the origin of a compound biological product |
| JP2012501681A (ja) | 2008-09-12 | 2012-01-26 | ジェンボールト コーポレイション | 生体分子の貯蔵および安定化のためのマトリックスおよび媒体 |
| EP2438016B1 (en) | 2009-06-05 | 2021-06-02 | IntegenX Inc. | Universal sample preparation system and use in an integrated analysis system |
| US8763642B2 (en) | 2010-08-20 | 2014-07-01 | Integenx Inc. | Microfluidic devices with mechanically-sealed diaphragm valves |
| EP2606154B1 (en) | 2010-08-20 | 2019-09-25 | Integenx Inc. | Integrated analysis system |
| JPWO2012046859A1 (ja) * | 2010-10-07 | 2014-02-24 | 日本碍子株式会社 | 識別対象を識別するための識別情報の保持体及びその利用 |
| US10865440B2 (en) | 2011-10-21 | 2020-12-15 | IntegenX, Inc. | Sample preparation, processing and analysis systems |
| US20150136604A1 (en) | 2011-10-21 | 2015-05-21 | Integenx Inc. | Sample preparation, processing and analysis systems |
| CN110560187B (zh) | 2013-11-18 | 2022-01-11 | 尹特根埃克斯有限公司 | 用于样本分析的卡盒和仪器 |
| US10208332B2 (en) | 2014-05-21 | 2019-02-19 | Integenx Inc. | Fluidic cartridge with valve mechanism |
| CN107106983B (zh) | 2014-10-22 | 2021-04-16 | 尹特根埃克斯有限公司 | 用于样品制备、处理和分析的系统和方法 |
| US10760182B2 (en) * | 2014-12-16 | 2020-09-01 | Apdn (B.V.I.) Inc. | Method and device for marking fibrous materials |
| CN105139048B (zh) * | 2015-08-24 | 2018-01-19 | 汪风珍 | 一种双号码证件及人证识别系统 |
| US11591755B2 (en) | 2015-11-03 | 2023-02-28 | Kimberly-Clark Worldwide, Inc. | Paper tissue with high bulk and low lint |
| HUP1600687A2 (hu) * | 2016-12-23 | 2018-06-28 | Avicor Kutato | Nukleinsav alapú kódolási eljárás |
| MX2019012303A (es) | 2017-04-28 | 2020-02-05 | Kimberly Clark Co | Laminas fibrosas formadas por espuma con fibras cortas rizadas. |
| AU2017441040B2 (en) | 2017-11-29 | 2023-12-21 | Kimberly-Clark Worldwide, Inc. | Fibrous sheet with improved properties |
| CN112469857B (zh) | 2018-07-25 | 2022-06-17 | 金伯利-克拉克环球有限公司 | 用于制备三维泡沫铺设的非织造物的方法 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002530121A (ja) * | 1998-11-25 | 2002-09-17 | プロメガ コーポレイション | 短いタンデム反復遺伝子座の多重増幅 |
| JP2004507746A (ja) * | 2000-09-01 | 2004-03-11 | ザ セクレタリー オブ ステイト フォー ザ ホーム デパートメント | マーキングの改良及びマーキングに関連するもの |
Family Cites Families (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1232617A (en) * | 1916-01-25 | 1917-07-10 | John L Shipp | Spring hair-remover. |
| US1588387A (en) * | 1923-12-26 | 1926-06-08 | Li Chin Leong | Hair-removing instrument |
| US1743590A (en) * | 1928-11-14 | 1930-01-14 | Binz Matilde | Hair puller |
| US2533801A (en) * | 1947-05-05 | 1950-12-12 | William R Heilig | Tweezers |
| US2486616A (en) * | 1947-11-22 | 1949-11-01 | Carl J Schubiger | Hair tweezer |
| US3152593A (en) * | 1962-06-28 | 1964-10-13 | Maurice M Cohen | Hair extracting device |
| JPS51145668A (en) * | 1975-06-10 | 1976-12-14 | Chitose Shokai:Kk | Hair-tweezers |
| US4394930A (en) * | 1981-03-27 | 1983-07-26 | Johnson & Johnson | Absorbent foam products |
| US5034506A (en) * | 1985-03-15 | 1991-07-23 | Anti-Gene Development Group | Uncharged morpholino-based polymers having achiral intersubunit linkages |
| US4658456A (en) * | 1985-10-17 | 1987-04-21 | Tsai Su Jem | Multi-purpose scissors |
| US4754768A (en) * | 1986-12-29 | 1988-07-05 | Jabouri Jal H | Hair plucking mechanism |
| IL82002A0 (en) * | 1987-03-25 | 1987-10-20 | Gen Ideas & Prod Ltd | Depilatory device |
| IL87833A0 (en) * | 1988-09-22 | 1989-03-31 | Daar Yair | Depilatory device |
| US5756126A (en) * | 1991-05-29 | 1998-05-26 | Flinders Technologies Pty. Ltd. | Dry solid medium for storage and analysis of genetic material |
| US4988353A (en) * | 1988-11-11 | 1991-01-29 | Hair Remover Ltd. | Depilatory device and hair-plucker body for use therein |
| FR2639803B1 (fr) * | 1988-12-07 | 1991-02-15 | Demeester Jacques | Appareil a epiler |
| IL89037A0 (en) * | 1989-01-23 | 1989-08-15 | Noach Amit | Improved spring element for hair-removal device |
| IL90433A (en) * | 1989-05-26 | 1993-04-04 | Yair Daar Moshav Galia And Shi | Depilatory device |
| US6040138A (en) * | 1995-09-15 | 2000-03-21 | Affymetrix, Inc. | Expression monitoring by hybridization to high density oligonucleotide arrays |
| EP0456915A1 (de) * | 1990-05-17 | 1991-11-21 | Koninklijke Philips Electronics N.V. | Epilationsapparat |
| US5133722A (en) * | 1990-07-23 | 1992-07-28 | Elecsys Ltd | Method and device for plucking hair |
| US5223618A (en) * | 1990-08-13 | 1993-06-29 | Isis Pharmaceuticals, Inc. | 4'-desmethyl nucleoside analog compounds |
| US5378825A (en) * | 1990-07-27 | 1995-01-03 | Isis Pharmaceuticals, Inc. | Backbone modified oligonucleotide analogs |
| DE69230781T2 (de) * | 1991-12-23 | 2000-09-21 | Koninkl Philips Electronics Nv | Haarentfernungsgerät mit verdrehender Wirkung |
| US6087186A (en) * | 1993-07-16 | 2000-07-11 | Irori | Methods and apparatus for synthesizing labeled combinatorial chemistry libraries |
| FR2709933B1 (fr) * | 1993-09-15 | 1996-05-15 | Seb Sa | Appareil à épilation mécanique par arrachage de poils sur la peau. |
| DE4439896A1 (de) * | 1994-11-08 | 1996-05-09 | Reinhard Prof Dr Szibor | Verfahren und Mittel zur "inneren Nummerierung" von Produkten sowie von Proben |
| AU701932B2 (en) * | 1994-12-08 | 1999-02-11 | Pabio | Chemical labelling of objects |
| US5776737A (en) * | 1994-12-22 | 1998-07-07 | Visible Genetics Inc. | Method and composition for internal identification of samples |
| AU693023B2 (en) * | 1995-05-05 | 1998-06-18 | Applied Biosystems, Llc | Methods and reagents for combined PCR amplification and hybridization probing assay |
| US6165182A (en) * | 1995-11-28 | 2000-12-26 | U.S. Philips Corporation | Depilation apparatus with vibration member |
| US6232124B1 (en) * | 1996-05-06 | 2001-05-15 | Verification Technologies, Inc. | Automated fingerprint methods and chemistry for product authentication and monitoring |
| US5643287A (en) * | 1996-05-09 | 1997-07-01 | Capehead Enterprises, Inc. | Depilatory device |
| JP3098971B2 (ja) * | 1996-05-15 | 2000-10-16 | 松下電工株式会社 | 脱毛装置 |
| US5899910A (en) * | 1996-09-17 | 1999-05-04 | Etman; Sameer A. | Direct acting cam gripping mechanism |
| JP3410645B2 (ja) * | 1997-02-25 | 2003-05-26 | 松下電工株式会社 | 脱毛装置 |
| US5908425A (en) * | 1997-09-22 | 1999-06-01 | Adam; Helen | Depilatory device and method of use |
| ATE224658T1 (de) * | 1997-10-17 | 2002-10-15 | Braun Gmbh | Epilationsgerät |
| CN1252697A (zh) * | 1997-12-16 | 2000-05-10 | 皇家菲利浦电子有限公司 | 仅具有扭转动作的拔毛装置 |
| US6159222A (en) * | 1998-03-17 | 2000-12-12 | Soft Lines Ltd. | Device for hair removal |
| US5951573A (en) * | 1998-05-15 | 1999-09-14 | Yashar; Parviz | Manual depilatory device |
| US6750059B1 (en) * | 1998-07-16 | 2004-06-15 | Whatman, Inc. | Archiving of vectors |
| US6153389A (en) * | 1999-02-22 | 2000-11-28 | Haarer; Brian K. | DNA additives as a mechanism for unambiguously marking biological samples |
| AU4033500A (en) * | 1999-03-25 | 2000-10-09 | Hyseq, Inc. | Solution-based methods and materials for sequence analysis by hybridization |
| CA2367400A1 (en) * | 1999-04-06 | 2000-10-12 | Yale University | Fixed address analysis of sequence tags |
| AU4701200A (en) * | 1999-05-07 | 2000-11-21 | Quantum Dot Corporation | A method of detecting an analyte using semiconductor nanocrystals |
| DE10055368A1 (de) * | 2000-11-08 | 2002-05-29 | Agrobiogen Gmbh Biotechnologie | Verfahren zur Kennzeichnung von DNA enthaltenden Proben mittels Oligonukleotiden |
| US20020128664A1 (en) * | 2001-03-07 | 2002-09-12 | Moghadam Atusa Houshidari | Manual depilatory device |
| US20040101876A1 (en) * | 2002-05-31 | 2004-05-27 | Liat Mintz | Methods and systems for annotating biomolecular sequences |
| WO2004097371A2 (en) * | 2003-04-25 | 2004-11-11 | Board Of Regents, The University Of Texas System | System and method for the detection of analytes |
-
2003
- 2003-04-29 US US10/426,940 patent/US20040219533A1/en not_active Abandoned
-
2004
- 2004-04-29 WO PCT/US2004/013545 patent/WO2005012574A2/en not_active Ceased
- 2004-04-29 EP EP04775927A patent/EP1623045A2/en not_active Withdrawn
- 2004-04-29 JP JP2006532530A patent/JP2007500013A/ja active Pending
-
2007
- 2007-02-23 US US11/678,402 patent/US20070218485A1/en not_active Abandoned
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002530121A (ja) * | 1998-11-25 | 2002-09-17 | プロメガ コーポレイション | 短いタンデム反復遺伝子座の多重増幅 |
| JP2004507746A (ja) * | 2000-09-01 | 2004-03-11 | ザ セクレタリー オブ ステイト フォー ザ ホーム デパートメント | マーキングの改良及びマーキングに関連するもの |
Non-Patent Citations (1)
| Title |
|---|
| JPN6010026156, Ｅｌｅｃｔｒｏｐｈｏｒｅｓｉｓ, 2001, Ｖｏｌ．２２，Ｎｏ．１６, ｐ．３５３３−３５３８ * |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006169336A (ja) * | 2004-12-15 | 2006-06-29 | Nissan Motor Co Ltd | 情報化核酸含有透明樹脂組成物 |
| JP2006169337A (ja) * | 2004-12-15 | 2006-06-29 | Nissan Motor Co Ltd | 不透明樹脂組成物 |
| JP2017112841A (ja) * | 2015-12-21 | 2017-06-29 | 株式会社テクノサイエンス | 検体管理方法 |
| JPWO2020129462A1 (ja) * | 2018-12-21 | 2021-11-11 | ソニーグループ株式会社 | 粒子確認方法、粒子捕捉用チップ、及び粒子分析システム |
| JP7435450B2 (ja) | 2018-12-21 | 2024-02-21 | ソニーグループ株式会社 | 粒子確認方法、粒子捕捉用チップ、及び粒子分析システム |
| JP2024036647A (ja) * | 2018-12-21 | 2024-03-15 | ソニーグループ株式会社 | 粒子確認方法、粒子捕捉用チップ、及び粒子分析システム |
| US12313639B2 (en) | 2018-12-21 | 2025-05-27 | Sony Corporation | Particle confirming method, particle trapping chip, and particle analyzing system |
| JP7740398B2 (ja) | 2018-12-21 | 2025-09-17 | ソニーグループ株式会社 | 粒子確認方法、粒子捕捉用チップ、及び粒子分析システム |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005012574A2 (en) | 2005-02-10 |
| EP1623045A2 (en) | 2006-02-08 |
| WO2005012574A3 (en) | 2005-08-04 |
| US20040219533A1 (en) | 2004-11-04 |
| US20070218485A1 (en) | 2007-09-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007535921A (ja) | 生物学的バーコード | |
| JP2007500013A (ja) | 生物学的バーコード | |
| US20100075858A1 (en) | Biological bar code | |
| CA2653095C (en) | Systems and methods for analyzing nanoreporters | |
| US20150141264A1 (en) | In-field dna extraction, detection and authentication methods and systems therefor | |
| US7894998B2 (en) | Method for identifying suitable nucleic acid probe sequences for use in nucleic acid arrays | |
| JP7071341B2 (ja) | 試料を識別する方法 | |
| US20040101845A1 (en) | Methods designing multiple mRNA transcript nucleic acid probe sequences for use in nucleic acid arrays | |
| JP2007500013A5 (enExample) | ||
| WO1998006084A1 (en) | A method of nucleic acid code analystic technique used in falseproof label | |
| WO2016032562A1 (en) | In-field dna extraction, detection and authentication methods and systems therefor | |
| CN102634587B (zh) | Dna芯片组合延伸检测碱基连续突变的方法 | |
| US20230125457A1 (en) | Synthetic molecular tags for supply chain tracking | |
| US10927405B2 (en) | Molecular tag attachment and transfer | |
| US20060073486A1 (en) | Multiple array substrates and methods for using the same | |
| US20060078891A1 (en) | Nucleic acid arrays comprising a set of hybridization parameter determination features and methods for using the same | |
| TW201634699A (zh) | 現場去氧核醣核酸萃取、檢測與驗證之方法及其系統 | |
| US20070166714A1 (en) | Methods for preparing gene chips and use thereof | |
| JP2002181821A (ja) | 複数検査多重化用懸濁液およびその懸濁液を用いた複数検査多重化方法 | |
| JP2010273568A (ja) | 核酸アレイ及び核酸アレイの識別方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070423 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070423 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070528 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100513 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20100812 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20100819 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20100910 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20100917 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20100922 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20100930 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20110124 |